Story of a Stock

A fundamental screener that adds business story, management commentary, and qualitative context to the numbers.

Explore

Coverage Universe

How Scores Work

Connect

X (Twitter)Telegram group (opens in a new tab)Submit Request

Built by Pranav Yadav

Experimental research workflow for Indian equity scuttlebutt. Not investment advice.

Research platformStory of a Stock

Results·7 today

Story of a Stock

Results·7 today

Desk Filings Ranking Journal Scanners

Sign in Sign up

Marksans Pharma Limited (MARKSANS) — concall analysis | Story of a Stock

Marksans Pharma Limited

SoaS score

6.3/10

Peaking

Healthcare/Pharmaceuticals9th of 12 in sector

Global pharma company focused on OTC & Rx generics The stock's story hinges on Goa Unit 2 ramping to meet a $220M US order book and fuel Europe's INR180cr FY27 push; momentum is steady.

When a section on Marksans Pharma Limited changes, it gets posted in the Telegram group first.

Join on Telegram→ (opens in a new tab)

Marksans Pharma Limited

SoaS score

6.3/10

Peaking

Healthcare/Pharmaceuticals9th of 12 in sector

Global pharma company focused on OTC & Rx generics The stock's story hinges on Goa Unit 2 ramping to meet a $220M US order book and fuel Europe's INR180cr FY27 push; momentum is steady.

Evenly split

53 / 100

The goodThe bad

The good

The bad

Where it sits